Division of Vascular Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Eur J Vasc Endovasc Surg. 2010 Mar;39 Suppl 1:S49-54. doi: 10.1016/j.ejvs.2009.12.020. Epub 2010 Feb 12.
For the treatment of congenital vascular malformation (CVM), conservative, endovascular and/or surgical treatment have been sporadically attempted according to the type, location and clinical manifestations of the vascular lesions. At current practice, with no established treatment guidelines for CVM patients, there is much room for ineffective interventions and occurrence of complications related with the treatment. Therefore, it is important to select proper candidates for the endovascular or surgical treatment in CVM patients to avoid ineffective treatment and its complications and to obtain better treatment results. We describe the basic considerations before the selection of candidates for percutaneous embolo-sclerotherapy in patients with CVM based on our own experiences at a specialised CVM clinic.
对于先天性血管畸形(CVM)的治疗,根据血管病变的类型、位置和临床表现,偶尔会尝试保守治疗、血管内治疗和/或手术治疗。目前,由于没有针对 CVM 患者的既定治疗指南,因此存在许多无效干预和与治疗相关的并发症发生的空间。因此,对于 CVM 患者,选择适当的血管内或手术治疗候选人非常重要,以避免无效治疗及其并发症,并获得更好的治疗效果。我们根据在专门的 CVM 诊所的经验,描述了在选择 CVM 患者经皮栓塞硬化治疗候选人之前的基本考虑因素。